Breaking News Instant updates and real-time market news.

ERI

Eldorado Resorts

$43.85

0.55 (1.27%)

, PAY

Verifone

$23.00

-0.02 (-0.09%)

18:05
08/14/18
08/14
18:05
08/14/18
18:05

S&P announces changes to S&P MidCap 400 index

S&P Dow Jones Indices will make the following changes to the S&P MidCap 400: Eldorado Resorts (ERI) will replace VeriFone Systems (PAY) in the S&P MidCap 400 effective prior to the open of trading on Monday, August 20. Francisco Partners is acquiring VeriFone Systems in a deal expected to be completed soon pending final conditions. Adient (ADNT) will replace DCT Industrial Trust (DCT) in the S&P MidCap 400 effective prior to the open of trading on Wednesday, August 22. S&P 500 constituent ProLogis (PLD) is acquiring DCT Industrial Trust in a deal expected to be completed soon pending final conditions.

ERI

Eldorado Resorts

$43.85

0.55 (1.27%)

PAY

Verifone

$23.00

-0.02 (-0.09%)

ADNT

Adient

$42.65

0.19 (0.45%)

DCT

DCT Industrial

$65.28

-0.34 (-0.52%)

PLD

Prologis

$64.05

-0.38 (-0.59%)

ERI Eldorado Resorts
$43.85

0.55 (1.27%)

06/12/18
ROTH
06/12/18
NO CHANGE
Target $60
ROTH
Buy
Eldorado Resorts price target raised to $60 from $56 at Roth Capital
Roth Capital analyst David Bain raised his price target for Eldorado Resorts to $60 from $56, while reiterating a Buy rating on the shares. The analyst believes there is a solid investment case for about $108 per share value based on reasonable CY21 operational and valuation assumptions. Further, Bain believes there is a strong possibility the company will announce another large-scale accretive acquisition within the next 18 to 24-months.
05/04/18
RHCO
05/04/18
NO CHANGE
Target $49
RHCO
Buy
Eldorado Resorts price target raised to $49 from $37 at SunTrust
SunTrust analyst C. Patrick Scholes raised his price target on Eldorado Resorts to $49 and kept his Buy rating after its Q1 results. Schoes says that despite the earnings miss on weather-related factors, the company's longer term opportunities of a Florida JV and pending purchases look compelling.
05/14/18
JEFF
05/14/18
NO CHANGE
JEFF
Jefferies says Penn National, Caesars among winners from sports gaming ruling
After the Supreme Court ruled that the PASPA provision prohibiting state authorization of organized sports gambling violates the tenth amendment, Jefferies analyst David Katz reiterated his view on which companies are positioned to be key beneficiaries of the decision. He continues to identify Penn National (PENN) and Caesars (CSR) as among the top winners in terms of casino operators, followed by Eldorado Resorts (ERI), Churchill Downs (CHDN), Boyd Gaming (BYD), Monarch Casino (MCRI), and MGM Resorts (MGM). He also sees "location-agnostic" suppliers Scientific Games (SGMS) and International Game (IGT) as winners, Katz tells investors.
05/08/18
NOMU
05/08/18
INITIATION
Target $47
NOMU
Neutral
Eldorado Resorts initiated with a Neutral at Nomura Instinet
Nomura Instinet analyst Henry Curtis started Eldorado Resorts with a Neutral rating and $47 price target.
PAY Verifone
$23.00

-0.02 (-0.09%)

04/10/18
CHLM
04/10/18
DOWNGRADE
Target $23.04
CHLM
Hold
Verifone downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Brad Berning downgraded Verifone to Hold from Buy after the company announced its intention to be acquired by an investment group led by Francisco Partners for $3.4B or $23.04 a share. The analyst also lowered his price target on the shares to $23.04 from $24 given he believes a higher bid is unlikely.
04/16/18
JEFF
04/16/18
DOWNGRADE
Target $23
JEFF
Hold
Verifone downgraded to Hold from Buy at Jefferies
Jefferies analyst Ramsey El-Assal downgraded Verifone Systems to Hold while raising his price target for the shares to $23 from $22. The downgrade follows Verifone's definitive agreement to be acquired by an investor group led by Francisco Partners for $23.04 a share in cash.
04/11/18
TIGR
04/11/18
DOWNGRADE
TIGR
Neutral
Verifone downgraded to Neutral from Buy at Tigress Financial
Verifone has agreed to be acquired by an investor group led by Francisco Partners for $23.04 per share in cash. Tigress Financial analyst Ivan Feinseth downgraded Verifone to Neutral as he believes based on the friendly nature of the deal and the premium being paid that there is little likelihood of another offer.
04/10/18
STPT
04/10/18
DOWNGRADE
STPT
Hold
Verifone downgraded to Hold from Buy at Standpoint Research
Standpoint Research analyst Ronnie Moas downgraded Verifone to Hold from Buy after the company announced its intention to be acquired by an investment group led by Francisco Partners for $3.4B or $23.04 a share.
ADNT Adient
$42.65

0.19 (0.45%)

07/27/18
BARD
07/27/18
UPGRADE
Target $52
BARD
Neutral
Adient upgraded to Neutral at Baird
As reported previously, Baird analyst David Leiker upgraded Adient to Neutral form Underperform. The analyst cited the sequential stability in the company's results, stating that he now sees upside opportunity and downside risk being in balance. Leiker, who said visibility and execution on action plans to improve operational performance are needed to drive more upside, has a $52 price target on Adient shares.
07/31/18
MSCO
07/31/18
DOWNGRADE
MSCO
Underweight
Adient downgraded to Underweight from Equal Weight at Morgan Stanley
07/31/18
07/31/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. CBS (CBS) downgraded to Market Perform from Outperform at Cowen with analyst Doug Creutz saying the combination of the legal fight with National Amusements, the potential for a recombination with Viacom (VIAB) and the allegations of sexual harassment against CEO Les Moonves create "too many unquantifiable variables." 2. Caterpillar (CAT) downgraded to Equal Weight from Overweight at Barclays with analyst Adam Seiden saying the company's largest end-markets are no longer at trough. Further, he believes Caterpillar's second half of 2018 price initiatives, directed towards offsetting supply chain and materials cost increases, will limit its ability to expand margins. 3. WisdomTree (WETF) downgraded to Sell from Neutral at Citi with analyst William Katz saying he believes WisdomTree's price-to-earnings multiple can further contract amid mixed flow dynamics and flat earnings growth prospects out to 2020. 4. Adient (ADNT) downgraded to Underweight from Equal Weight at Morgan Stanley. 5. Tupperware Brands (TUP) downgraded to Sell from Hold at Argus with analyst Deborah Ciervo citing the company's disappointing Q2 revenue and reduced outlook for FY18. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/31/18
07/31/18
UPGRADE

Overweight
Lear upgraded to Overweight, Adient cut to Underweight at Morgan Stanley
As previously reported, Morgan Stanley analyst Armintas Sinkevicius upgraded Lear (LEA) to Overweight from Equal Weight with the stock trading at a discount to Adient (ADNT), which he also downgraded to Underweight this morning. Lear has a strong operational track record and history of "beat and raise quarters" and Sinkevicius sees upside to estimates and the stock's multiple, he tells investors. Meanwhile, Adient management has recently lowered guidance for the Seating business due to further operational challenges, leaving the analyst seeing limited upside to numbers in the near term, he tells investors. Sinkevicius lowered his price target on Adient shares to $43 from $50 and raised his price target on Lear to $214 from $209.
DCT DCT Industrial
$65.28

-0.34 (-0.52%)

04/30/18
JMPS
04/30/18
NO CHANGE
JMPS
Market Perform
Other bidders unlikely for DCT Industrial, says JMP Securities
After DCT Industrial (DCT) announced an agreement to be acquired by Prologis (PLD) in a stock-for-stock transaction valued at $8.4B, including debt, JMP Securities analyst Mitch Germain said he does not expect another bidder to emerge given the "full" pricing for the deal. He does, however, anticipate the potential for additional sector M&A activity, citing the pricing dynamic between public and private real estate, record levels of private equity dry powder on the sidelines and "readily available" debt financing. Germain has a Market Perform rating on DCT Industrial shares.
05/01/18
RAJA
05/01/18
UPGRADE
RAJA
Market Perform
DCT Industrial upgraded to Market Perform from Underperform at Raymond James
05/14/18
WELS
05/14/18
DOWNGRADE
WELS
Market Perform
DCT Industrial downgraded to Market Perform from Outperform at Wells Fargo
05/14/18
05/14/18
DOWNGRADE

Market Perform
DCT Industrial downgraded to Market Perform at Wells Fargo
As previously reported, Wells Fargo analyst Blaine Heck downgraded DCT Industrial (DCT) to Market Perform from Outperform, while raising his price target on the shares to $67 from $65, given the company's expected acquisition by Prologis (PLD).
PLD Prologis
$64.05

-0.38 (-0.59%)

04/30/18
KEYB
04/30/18
NO CHANGE
KEYB
Prologis acquisition of DCT Industrial an affirmation of infill strategy, says KeyBanc
KeyBanc analyst Craig Mailman notes that Prologis (PLD) announced plans to acquire DCT (DCT) for $8.4B in a stock for stock deal at a 4.3% going-in cap rate. The analyst views the transaction as an affirmation of the infill strategy, as DCT represents the next best domestic platform among the larger industrial REIT portfolios.
04/30/18
JEFF
04/30/18
NO CHANGE
Target $57
JEFF
Hold
Prologis paid a steep price for DCT Industrial, says Jefferies
Prologis (PLD) is paying a steep price to acquire DCT Industrial's (DCT) high-quality U.S. warehouse portfolio, but management expects 6c-8c of accretion after $80M of cost synergies, Jefferies analyst Jonathan Peters tells investors in a research note. At first glance, the cost synergy estimates appear aggressive, the analyst adds. He believes, however, that the combination of the well-located portfolios should drive solid organic revenue growth.

TODAY'S FREE FLY STORIES

MU

Micron

$46.06

1.01 (2.24%)

16:52
09/20/18
09/20
16:52
09/20/18
16:52
Hot Stocks
Micron says it achieved record revenue in FY18 »

Says expects 1ynm sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

PMBC

Pacific Mercantile Bancorp

$9.75

0.025 (0.26%)

16:50
09/20/18
09/20
16:50
09/20/18
16:50
Hot Stocks
Breaking Hot Stocks news story on Pacific Mercantile Bancorp »

EJF Capital reports 7.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

MU

Micron

$46.06

1.01 (2.24%)

16:46
09/20/18
09/20
16:46
09/20/18
16:46
Hot Stocks
Breaking Hot Stocks news story on Micron »

Micron up 5.7% to $48.69…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

BHBK

Blue Hills Bancorp

$23.55

0.4 (1.73%)

16:45
09/20/18
09/20
16:45
09/20/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Blue Hills Bancorp »

Blue Hills Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$24.82

0.17 (0.69%)

16:44
09/20/18
09/20
16:44
09/20/18
16:44
Initiation
Teva initiated  »

Teva assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

CRSP

Crispr Therapeutics

$48.90

-3 (-5.78%)

16:44
09/20/18
09/20
16:44
09/20/18
16:44
Initiation
Crispr Therapeutics initiated  »

Crispr Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Sep

NTLA

Intellia Therapeutics

$31.50

-0.48 (-1.50%)

16:44
09/20/18
09/20
16:44
09/20/18
16:44
Initiation
Intellia Therapeutics initiated  »

Intellia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

EDIT

Editas Medicine

$32.55

-0.64 (-1.93%)

16:43
09/20/18
09/20
16:43
09/20/18
16:43
Initiation
Editas Medicine initiated  »

Editas Medicine initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMC

Western Asset Mortgage

$11.30

0.055 (0.49%)

16:42
09/20/18
09/20
16:42
09/20/18
16:42
Syndicate
Western Asset Mortgage 6.5M share Spot Secondary; price range $10.85-$11.10 »

Morgan Stanley,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$20.00

0.4 (2.04%)

16:41
09/20/18
09/20
16:41
09/20/18
16:41
Initiation
Vanda Pharmaceuticals initiated  »

Vanda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

WYNN

Wynn Resorts

$137.32

1.64 (1.21%)

16:41
09/20/18
09/20
16:41
09/20/18
16:41
Hot Stocks
Breaking Hot Stocks news story on Wynn Resorts »

Lone Pine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

, RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

16:41
09/20/18
09/20
16:41
09/20/18
16:41
Periodicals
Shell in discussions to sell $1.3B in Gulf Coast assets, Bloomberg says »

Royal Dutch Shell is in…

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPVG

TriplePoint Venture

$12.97

-0.01 (-0.08%)

16:39
09/20/18
09/20
16:39
09/20/18
16:39
Initiation
TriplePoint Venture initiated  »

TriplePoint Venture…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMPH

KemPharm

$4.70

-0.25 (-5.05%)

16:38
09/20/18
09/20
16:38
09/20/18
16:38
Initiation
KemPharm initiated  »

KemPharm assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLL

Ball Corp.

$44.39

0.15 (0.34%)

16:35
09/20/18
09/20
16:35
09/20/18
16:35
Hot Stocks
Ball Corp. CFO Scott Morrison sells over $1M in company shares »

Ball Corp. CFO Scott…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLIT

Harmonic

$5.20

0.15 (2.97%)

16:34
09/20/18
09/20
16:34
09/20/18
16:34
Initiation
Harmonic initiated  »

Harmonic initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

WMC

Western Asset Mortgage

$11.30

0.055 (0.49%)

16:34
09/20/18
09/20
16:34
09/20/18
16:34
Syndicate
Western Asset Mortgage files to sell 6.5M shares of common stock »

Morgan Stanley, BofA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,944.26

17.99 (0.93%)

, AAPL

Apple

$220.00

1.655 (0.76%)

16:33
09/20/18
09/20
16:33
09/20/18
16:33
Periodicals
Twitch appears to be blocked in China, Abacus reports »

Amazon's (AMZN)…

AMZN

Amazon.com

$1,944.26

17.99 (0.93%)

AAPL

Apple

$220.00

1.655 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WMC

Western Asset Mortgage

$11.30

0.055 (0.49%)

16:32
09/20/18
09/20
16:32
09/20/18
16:32
Syndicate
Western Asset Mortgage files to sell 6.5M shares of common stock »

Morgan Stanley, BofA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$70.79

0.8 (1.14%)

16:32
09/20/18
09/20
16:32
09/20/18
16:32
Hot Stocks
Merck receives positive CHMP opinion for DELSTRIGO and PILFETRO in E.U. »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 23

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

16:30
09/20/18
09/20
16:30
09/20/18
16:30
Options
Preliminary option volume of 24.2M today »

Preliminary option volume…

INDB

Independent Bank

$89.85

0.65 (0.73%)

, BHBK

Blue Hills Bancorp

$23.55

0.4 (1.73%)

16:29
09/20/18
09/20
16:29
09/20/18
16:29
Hot Stocks
Independent Bank to acquire Blue Hills Bancorp »

Independent Bank (INDB),…

INDB

Independent Bank

$89.85

0.65 (0.73%)

BHBK

Blue Hills Bancorp

$23.55

0.4 (1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTV

Veritiv

$44.70

-0.65 (-1.43%)

16:29
09/20/18
09/20
16:29
09/20/18
16:29
Syndicate
Veritiv files to sell 1.5M shares of common stock for holders »

Morgan Stanley is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTV

Veritiv

$44.70

-0.65 (-1.43%)

16:29
09/20/18
09/20
16:29
09/20/18
16:29
Syndicate
Veritiv files to sell 1.5M shares of common stock for UWW Holdings, LLC »

Morgan Stanley & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FATE

Fate Therapeutics

$14.02

0.67 (5.02%)

16:26
09/20/18
09/20
16:26
09/20/18
16:26
Syndicate
Fate Therapeutics $100M Spot Secondary; re-offered at $13.50 »

Jefferies, Piper Jaffray…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 21

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.